Found "Public health policy": 1,082 results
Policy Brief: Conducive Factors to HTA Development in Asia
The Health Technology Assessment (HTA), which is a crucial tool for setting health intervention priorities, has been rapidly developing in Asia-Pacific, but is still not fully employed by many countries in policy decision making. Although HTA institutions and networks have been operating successfully in OECD countries and a few of the middle-income
GEAR
WWW.GEAR4HEALTH.COM In 2016, the HITAP International Unit will launch the Guide to Economic Analysis and Research (GEAR) Database. The GEAR database is intended as a tool for identifying and resolving gaps and technical issues in economic evaluations. The database is de
Introduction of Pneumococcal Conjugate Vaccine (PCV) in Bhutan
In September 2016, Bhutan Ministry of Health (MOH) approached HITAP to provide support to conduct an economic evaluation study to introduce PCV in Bhutan. With regards to the request, WHO Bhutan funded 4 of HITAP staffs (3 researchers and 1 project associate) to help conduct the study. This collaborative work between MOH, HITAP and WHO has a work p
GAVI Health Systems Strengthening Support (HSS) Study
The World Health Organization (WHO) requested HITAP to provide technical assistance to the Ministry of Health and Sports (MoHS) in Myanmar to complete a closure assessment of two health financing schemes under the GAVI Health Systems Strengthening Support (HSS) program. The study will apply a multi-pronged approach comprising a document review, a s
GAVI Health Systems Strengthening Support (HSS) Study
The World Health Organization (WHO) requested HITAP to provide technical assistance to the Ministry of Health and Sports (MoHS) in Myanmar to complete a closure assessment of two health financing schemes under the GAVI Health Systems Strengthening Support (HSS) program. The study will apply a multi-pronged approach comprising a document review, a s
A study to develop a quarantine guideline for medical and public health personnel who have been exposed to COVID-19
Project Consultant Dr. Yot Teerawattananon and Dr. Wanrudee Isaranuwatchai 63191002RM018L0quarantine guideline
Drug procurement in public hospitals under the Government Procurement and Supplies Management Act B.E. 2560
Project ConsultantSripen TantivessPattara LeelahavarongNetnapis Suchonwanich59002017R2021L4Drug procurement,price performance,public hospital,พระราชบัญญัติการจัดซื้อจัดจ้างและการบริหารพัสดุภาครัฐ
A synthesis of policy recommendations on budgeting of implementing sofosbuvir/velpatasvir as a pan-genotypic regimen for the treatment of chronic hepatitis C in Thailand
63231002RM 023L0Chronic Hepatitis C,HCV,Hepatitis C Virus,sof/vel,sofosbuvir,velpatasvir,ไวรัสตับอักเสบซี
การวิเคราะห์ต้นทุนระบบเฝ้าระวังในโรคป้องกันด้วยวัคซีน (หัดและหัดเยอรมัน) และต้นทุนส่วนเพิ่มเพื่อการกำจัดโรคหัดและหัดเยอรมันในประเทศไทย
Department of Immunization, Vaccines and Biologicals, World Health Organization (WHO) ได้รับการสนับสนุนเงินทุนจาก Global Alliance for Vaccines and Immunization (GAVI) และ the Centers for Disease Control and Prevention (US CDC) เพื่อริเริ่มโครงการพั
The Impact of Health Technology Assessment for the Support of Universal Health Coverage in Thailand
According to World Health Organization (WHO) health system framework an efficient health system results in equitable access to essential health technologies with assured quality, safety, efficacy, and cost-effectiveness. National policies, essential health technology list, and evidenced-based selection of health technologies using health technology
10 / Page